TIGER Study — Transthoracic Approach International GastroEsophageal Cancer Registry
tigerstudy.dev
LaunchIndex first observed TIGER Study — Transthoracic Approach International GastroEsophageal Cancer Registry (tigerstudy.dev) live on 15 August 2026. View its launch screenshot, category, technologies, and verification evidence.
A launch record built from evidence.
TIGER Study — Transthoracic Approach International GastroEsophageal Cancer Registry (tigerstudy.dev) was first observed live on 15 August 2026.
TIGER Study is a global, multicenter prospective registry that collects surgical data for esophageal cancer to map lymph node metastasis and guide evidence-based lymphadenectomy and benchmarking across institutions.
Its profile is classified as Professional service within Services / Professional services. Verification detected Next.js.
What the launch signal contained.
- First observed live
- Previous state
- No prior non-live observation
- Last verified
- Canonical host
- tigerstudy.dev
- Category
- Services / Professional services
- Website type
- Professional service
- Observed title
- TIGER Study — Transthoracic Approach International GastroEsophageal Cancer Registry
- Observed description
- TIGER Study is a multinational prospective registry for esophageal and gastroesophageal junction cancer surgery, collecting real-world data from institutions across 30+ countries to improve surgical outcomes.
- Detected technologies
- Next.js
- Screenshot captured
- Evidence source
- Browser observation · Local
- Evidence confidence
- 90%
- HTTP status
- 200
Is this your website?
Claim this profile to add verified owner information.
What do you make of this launch?
Vote on the site and leave a short note for other people exploring the new web.
Report an issueFlag spam, illegal or harmful content, or inaccurate information.
Reports are private and reviewed by the moderation team. No sign-in is required, so this report will be anonymous.
Join the discussion
Sign in with Google to vote or comment.
Sign in to participateComments
0 commentsBe the first to leave a useful observation.